Cartesian Therapeutics, Inc. (RNAC)

NASDAQ

$6.07

$-0.13

(-2.07%)

Regular Market

Cartesian Therapeutics, Inc. (RNAC) Live Price Chart

Last updated: ⁦2026-10-19 15:14:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cartesian Therapeutics, Inc. (RNAC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.07, with a market capitalization of $189.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.60 to $11.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$189.70M
Open	$6.28
Day's High	$41.87
Day's Low	$5.60
Previous Close	$6.27
Volume	96.38K
Average Volume	131.54K
P/E Ratio	--
52-Week High	$11.00
52-Week Low	$5.60
Dividend Yield	--
Earnings Date	--

Cartesian Therapeutics, Inc. (RNAC) Stock Price Today

Cartesian Therapeutics, Inc. (RNAC) is currently trading at $6.07 as of 2026-10-19 15:12:00, down 3.27% ($0.20) from the previous close of $6.27

During today's regular trading session, RNAC has traded between $5.60 and $41.87, with a trading volume of 96.38K shares. The current price is near the lower end of today's range.

Cartesian Therapeutics, Inc. (RNAC) 7-Day Stock Price Change

Over the past seven days, Cartesian Therapeutics, Inc. (RNAC) moved from $6.82 to $6.07, representing a decline of 11.07% ($0.75).

The stock traded between $6.03 and $7.17 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 146.90 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

RNAC 52-Week Price Position

Position in Range: 8.6%

52W Low$5.60

52W High$11.00

RNAC is currently trading at $6.07, placing it 8.6% of the way from its 52-week low of $5.60 to its 52-week high of $11.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cartesian Therapeutics, Inc. (RNAC)?

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Cartesian Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	75
Exchange	NASDAQ
Company Website	https://www.cartesiantherapeutics.com

How to Buy Cartesian Therapeutics, Inc. (RNAC) Stock on MEXC

Eligible investors can buy real shares of Cartesian Therapeutics, Inc. (RNAC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RNAC and Place Your Order

Open the RealStocks trading page and search for RNAC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cartesian Therapeutics, Inc. (RNAC) stock price today?

Cartesian Therapeutics, Inc. (RNAC) is currently trading at $ 6.07, down 3.27% ($0.20) from the previous close of $ 6.27. Intraday prices update in real time during regular trading hours.

2.Is RNAC stock going up or down today?

As of 2026-10-19 15:12:00, RNAC is trading at $ 6.07, down 3.27% ($0.20) from its previous close of $ 6.27. The stock has traded between $ 5.60 and $ 41.87 during today’s regular session. Past price movements do not guarantee future results.

3.What is RNAC pre-market price?

As of 2026-10-19 15:12:00, RNAC is trading at $ 6.26 in pre-market trading, down 0.16% ($0.01) from the previous close of $ 6.27. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RNAC after-hours price?

As of 2026-10-19 15:12:00, RNAC is trading at $ 6.26 in after-hours trading, down 0.16% ($0.01) from the regular-session close of $ 6.27. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RNAC stock trading now?

RNAC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RNAC sit relative to its 52-week high and low?

Over the past 52 weeks, RNAC has traded between a low of $ 5.60 and a high of $ 11.00. At $ 6.07, the stock is positioned 8.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cartesian Therapeutics, Inc. in?

Cartesian Therapeutics, Inc. (RNAC) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cartesian Therapeutics, Inc.'s market capitalization and where is it listed?

Cartesian Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 189.70M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RNAC valued in terms of P/E ratio and EPS?

RNAC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -5.09. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cartesian Therapeutics, Inc. pay a dividend?

Cartesian Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.